According to Star Combo Pharma latest financial reports the cash on hand of S66 is $6.42M, an decrease of -8.71% to 2022. At the end of 2022 company had $7.03M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $6.42M | -8.71% |
2022 | $7.03M | -40.01% |
2021 | $11.72M | -34.88% |
2020 | $18.00M | 475.65% |
2019 | $3.13M | - |